Most women learn they have MRKH at fifteen or sixteen, in a consulting room, in a sentence that takes about four seconds to say. Periods never started; a scan was ordered; the uterus is not there. What follows that sentence is often silence, or a leaflet, or a suggestion to come back in a few years.
This article is for the gap after that sentence. It is not a sales page — there is a separate clinical guide to uterus transplantation if that is what you came for. This one is about the diagnosis itself and the honest shape of the choices, including the ones that have nothing to do with us.
What MRKH actually is
Mayer-Rokitansky-Küster-Hauser syndrome is a congenital condition in which the uterus and the upper part of the vagina do not form, while the ovaries and the external anatomy develop normally. It occurs in approximately one in 4,500 female births.
The key fact, and the one most often missed in that four-second sentence, is that the ovaries work. They produce eggs. They produce hormones. Puberty happens on schedule — breast development, body shape, everything except menstruation, because there is no uterus for a period to come from.
There are two recognised types. In type I the uterus and upper vagina are absent and nothing else is affected. In type II, sometimes called MURCS, there are associated differences elsewhere — most often in the kidneys, and sometimes in the spine or hearing. This is why a new diagnosis is normally followed by a kidney ultrasound, and it is not a sign that something worse is suspected.
How it is usually found
Almost always through primary amenorrhoea: periods that never start, in a girl who has otherwise gone through puberty normally. By around sixteen, with breast development complete and no menstruation, an investigation begins.
An ultrasound is the usual first step, and an MRI often follows because it maps the anatomy more precisely. Hormone tests come back normal, which is itself informative — it rules out the conditions that would explain absent periods through ovarian failure. A karyotype is standard, and in MRKH it is 46,XX.
That last detail matters more than it sounds. Part of the distress around this diagnosis comes from confusion with conditions that are genetically different, and it is worth hearing clearly: MRKH is a difference in how one set of structures formed in the womb. Nothing else about the diagnosis is in question.
What the diagnosis does not mean
Several things get assumed in the first weeks that are simply not true, and they are worth naming.
- It does not mean infertility in the sense most people use the word. The eggs are there and they are yours. What is missing is the place to carry a pregnancy, not the material to start one. Every path below rests on that distinction.
- It does not mean hormone treatment for life. The ovaries do their own work; there is no deficiency to replace.
- It does not mean a sex life is off the table. Vaginal length can be increased, most often with dilator therapy over months — a first-line approach with good results that avoids surgery entirely. Surgical creation is available where dilation does not work.
- It does not mean it was caused by anything. MRKH is not inherited in a simple pattern, and nothing a parent did or did not do during pregnancy accounts for it.
The three paths, without the brochure voice
There are exactly three ways to a family from here, and they are not equally available to everyone. Which ones are open to you depends as much on where you live and your legal situation as on medicine, which is not how anybody expects this to work.
Uterus transplantation is the only one that ends in you carrying the pregnancy. It is real, it has produced live births, and it is rare, slow and uncertain. Surrogacy uses your own eggs and someone else carries; the child is genetically yours and the obstacles are legal rather than medical. Adoption is the path that does not depend on your body at all, and the one most often listed last and dismissed fastest.
A clinic that presents only the first of these is not giving you a choice. The sections below are an attempt at the other two as well.
Uterus transplantation: where it actually stands
Between the first attempt in 2000 and the end of 2024, more than 140 uterus transplants were performed worldwide, by the estimate of the Swedish team behind the first birth (Brännström et al., Reproductive Medicine and Biology, 2025). The first live birth came from Sweden in 2014, from a living donor; the first after a transplant from a deceased donor came from Brazil in December 2017. The operation works. It also fails, often early, and a substantial minority of grafts are removed within the first year.
Three features surprise almost everyone. The graft is temporary — removed after one or two births so immunosuppression can stop. IVF has to happen before the transplant, because a transplanted uterus is not connected to the fallopian tubes and every pregnancy begins as an embryo transfer. And the whole arc, from first consultation to a birth, runs three to five years in the cases that succeed.
In Türkiye there is a genuine programme history: the 2011 operation by the team of Prof. Ömer Özkan at Akdeniz University Hospital was the world's first uterus transplant from a deceased donor, and the recipient delivered nine years later. But every such operation here has used a deceased donor, and each case requires individual authorisation from the Ministry of Health. There is no programme to simply join. The full clinical guide sets out the eligibility, the risks and the legal limits in detail — including the restriction on assisted reproduction that rules this path out for a significant share of the women who ask about it.
Surrogacy: a legal map, not a medical one
Medically, surrogacy with MRKH is the straightforward option: your ovaries are stimulated, your eggs are collected and fertilised, and the embryo is transferred to a gestational carrier. The child is genetically yours. The medicine is routine IVF.
The difficulty is entirely jurisdictional, and it is substantial. Surrogacy is prohibited in Türkiye, so this is not something we can arrange and not something any Turkish clinic can lawfully offer you. Elsewhere the picture is a patchwork: some countries permit it with payment, some only altruistically, some ban it outright, and several that once welcomed international couples have since closed to them. Whether a child born this way will be recognised as yours in your own country is a separate question again, decided by your country's law rather than the one where the birth happened.
If this is the path you are considering, the person you need is a family lawyer in your own jurisdiction, before a clinic anywhere. We say this knowing it sends you away from us.
Adoption, said properly
Adoption gets listed third and treated as the consolation, which is both unkind and inaccurate. It is the only path that does not depend on your body, does not involve immunosuppressive drugs, and does not hinge on which country you happen to hold a passport from.
It has its own difficulty — waiting times, assessment, and in many countries a shortage of infants relative to applicants — and it deserves to be weighed on those terms rather than as the thing you settle for. Some women come to it after years of pursuing the other two; some decide early that the medical route is not what they want their twenties to be about. Both are reasonable.
How to decide, and who to ask
The decision is rarely made all at once, and it should not be made from a search results page. A few things make it easier.
- Get your own anatomy mapped properly. An MRI and a kidney ultrasound, if they have not already been done. Everything else follows from an accurate picture.
- Ask about ovarian reserve early. Every path except adoption rests on your eggs, and reserve declines with age regardless of which path you end up choosing. Knowing the number changes how urgent the rest feels.
- Get the legal answer before the medical one. For surrogacy especially, but for transplantation too: the rules in your country and the destination country decide more than any clinic will.
- Find other women with MRKH. Patient organisations exist in most countries and are consistently better than clinics at the parts nobody writes down.
- Be wary of confident percentages. Worldwide experience with transplantation is still small: by the end of 2024, more than 140 operations in all. Anyone quoting you a success rate for your situation before reading your file is not working from the evidence.
Where we fit, and where we do not
BergemHealth arranges treatment in Türkiye under direct contracts with the professors who take the case. On this subject that means a narrow but real offer: we can have your file reviewed by the relevant specialists and tell you honestly whether uterus transplantation is a path the Turkish framework can accommodate in your situation — including when the answer is no, which it often is. For uterus transplantation we work directly with Prof. Ömer Özkan: we will pass your records to him and his team and arrange a consultation with him personally — a conversation about your situation, not a promise of surgery.
What we cannot do is arrange surrogacy, which is prohibited here, or promise an operation that requires individual Ministry authorisation. If your situation points to surrogacy or adoption, we will say so and you will not hear from us again unless you ask.
For the clinical detail — eligibility, the IVF sequencing, the risks, the timeline — see the uterus transplantation guide. For the wider transplant programme, the organ transplantation section covers liver, kidney and bone marrow.